Solarvest BioEnergy Inc. (SVS.V)
| Previous Close | 0.0650 |
| Open | 0.0550 |
| Bid | 0.0550 x 0 |
| Ask | 0.0650 x 0 |
| Day's Range | 0.0550 - 0.0650 |
| 52 Week Range | 0.0400 - 0.2100 |
| Volume | |
| Avg. Volume | 32,275 |
| Market Cap | 5.134M |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Solarvest BioEnergy's New Fixed Stock Option Plan Accepted by TSXV; Option Grants to Directors, Officers and Consultants
Vancouver, British Columbia--(Newsfile Corp. - March 3, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") is pleased to announce that, further to its news releases of September 22 and November 3, 2022, the TSX Venture Exchange (the "Exchange") has accepted for filing its new fixed stock option plan (the "2022 Plan"). The 2022 Plan reserves a total of 11,067,000 common shares for issuance pursuant to the grant of stock options. All ...
- Newsfile
Solarvest BioEnergy's Non-Brokered Private Placement Receives Final Exchange Acceptance
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest", or the "Company"), is pleased to announce that, further to its news release of February 9, 2023, it has received final acceptance from the TSX Venture Exchange ("Exchange") for its previously announced non-brokered private placement (the "Offering") which closed in two tranches on December 16, 2022 (the "First Tranche") and February 7, 2023 (the "Second Tranche") respectively fo
- Newsfile
Solarvest BioEnergy Inc. Announces Grant of Stock Options, Re-Pricing of Existing Stock Options and Adoption of New Fixed Stock Option Plan
Vancouver, British Columbia--(Newsfile Corp. - September 22, 2022) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") announces that pursuant to the Company's existing Stock Option Plan, a total of 1,000,000 incentive stock options have been granted to a consultant of the Company. These stock options are exercisable at a price of $0.12 per share for a period of 2 years expiring August 1, 2024.The Company also wishes to announce that it intends ...
